Rosuvastatin 20 Mg Oral Tablet

DRUG5 trials

Conditions

Acute Coronary SyndromesCoronary Artery Disease ProgressionCoronary Artery Disease Risk Factors MultipleDiabetes MellitusHydroxymethylglutaryl-CoA Reductase InhibitorsNonalcoholic SteatohepatitisPeripheral Nerve DiseasePremature Atherosclerosis

Phase 2

Neuroprotection of Memantine and Rosuvastatin

Not yet recruitingNCT07504198

Tanta UniversityPeripheral Nerve Disease

Start: 2026-03-01End: 2027-05-01Target: 46Updated: 2026-03-31

Phase 3

Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis

NCT05731596

Tanta UniversityNonalcoholic Steatohepatitis

Start: 2023-06-30End: 2024-04-30Target: 46Updated: 2023-05-16

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

RecruitingNCT07232069

Duke UniversityCoronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression, Prevention & Control +1

Start: 2026-07-21End: 2031-07-01Target: 1500Updated: 2026-09-01

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients

Not yet recruitingNCT07736313

Assiut UniversityAcute Coronary Syndromes

Start: 2026-07-01End: 2029-09-01Target: 120Updated: 2026-07-30

Unknown Phase

Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome

CompletedNCT05306990

Helwan UniversityHydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes Mellitus

Start: 2017-04-20End: 2021-01-31Updated: 2022-04-01

Related Papers

Efficacy and Safety of Atorvastatin 40 mg versus Rosuvastatin 20 mg in Patients with Type 2 Diabetes Mellitus and Previous Acute Coronary Syndrome: A Randomized Clinical Trial